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Abstract – The aim of the study was to build a comprehensive picture of the appearance in the blood
stream of Ag-speciﬁc plasma cells and memory B cells in the bovine model. For this purpose, we have
developed a method allowing the detection and quantiﬁcation of both cell types within individual calves
immunised with ovalbumin. During the primary response, we detected a burst of ovalbumin-speciﬁc plasma
cells at days 6 and 7 post-immunisation, which was followed by the production of speciﬁc Ab, whereas
a gradual increase of memory B cells was only detected from day 15. As expected, a boost immunisation
performed 7 weeks later induced a quicker and stronger secondary response. Indeed, a burst of plasma
cells was detected in the blood at days 3 and 4, which was followed by a strong increase in Ab titres.
Furthermore, a burst of memory B cells, and not a gradual increase, was detected at days 5 and 6 post-boost
immunisation. Importantly, we showed a strong correlation between the anti-ovalbumin-speciﬁc IgG titres
detected 5 months after secondary immunisation and the plasma cell numbers detected in the blood at the
peak response after secondary immunisation. The detection and quantiﬁcation of plasma cells following an
immunisation/vaccination strategy could constitute a very effective means for predicting the magnitude and
longevity of an Ab response.
bovine immunology / memory B cells / plasma cells / humoral response / vaccines
1. INTRODUCTION
The traditional method for assessing a
B cell response generated after immunisa-
tion, vaccination or infection consists of
quantifying speciﬁc Ab titres in the serum.
Indeed, following a primary challenge with a
T-dependent Ag, there is an initial phase
when no speciﬁc Ab can be detected as it
takes 1 to 2 weeks to observe a logarithmic
rise of Ab titres, which then reach a plateau
before declining again. In the primary res-
ponse, the appearance of IgG is preceded by
IgM. In comparison, the Ab titres following
a secondary antigenic challenge appear more
quickly, reach a higher level and can persist
for very long periods of time. Moreover, the
* Corresponding author: eric.lefevre@bbsrc.ac.uk
secondary humoral response is characterised
by the predominance of Abs of the IgG sub-
class with a greater afﬁnity for the immunising
Ag.Thisrapidandspeciﬁcsecondaryresponse
is dependent on the recruitment and activation
of memory B cells (generated during the pri-
mary response), as these cells exhibit an intrin-
sic advantage over naïve B cells in both the
time to initiate a response and in the division-
based rate of effector cell development [17].
Even in the absence of re-immunisation, Ab
levels in the serum can still be maintained
for many years and even decades [12]. It is
believed these Ab levels are maintained by the
presence of long-lived plasma cells in the bone
marrow that secrete Ab for long periods of
time and/or the continuous differentiation of
memory B cells into plasma cells in an Ag-
independent manner [2,11,15]. Therefore, it is
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possible the enumeration of plasma cells and
memoryBcellsfollowingavaccination, rather
than only quantifying Ab titres, could provide
a means to predict earlier and more efﬁciently
the duration of immunity.
It is possible to detect plasma cells and
memory B cells in the blood by the ELISPOT
technique; the detection of the latter necessi-
tates stimulating these quiescent memory B
cells in order to induce their differentiation
into Ab-secreting cells (ASC). Various meth-
ods have previously been described for induc-
ing the differentiation of human memory B
cells. These methods involve the culture of
peripheral blood mononuclear cells (PBMC)
or puriﬁed B cells for 5 to 6 days in the
presence of polyclonal stimuli and cytokines,
such as Staphylococcus aureus Cowan I (SAC)
and interleukin (IL)-2 [7], pokeweed mitogen
(PWM), unmethylated CpG oligodeoxynu-
cleotides (CpG ODN) and SAC [5], CD40L-
transfected CDw32L mouse ﬁbroblasts plus
IL-2 and IL-10 [20] or CpG and IL-15 [2].
The detection of plasma cells and memory
B cells could also be useful for determining
the efﬁcacy of new vaccine formulations and
schedules in cattle. However, most of the
reagents used for stimulating human B cells
are not suitable when using bovine B cells.
Here, we describe a method allowing, in the
bovine model, the detection and quantiﬁcation
in the blood of both Ag-speciﬁc plasma
cells and memory B cells, using ovalbumin
as a model T-dependent Ag. Using this
model, we were able to sample sufﬁcient
amounts of blood at numerous time points
that allowed us to build a comprehensive
picture of the appearance of both these cell
types within individual calves and to establish
a correlation between the number of these
cells and Ab titres detected following a boost
immunisation.
2. MATERIALS AND METHODS
2.1. Calves and immunisation protocol
Calves (Bos taurus) were British Holstein
Friesians conventionally reared at the Institute for
Animal Health (Compton, UK). These animals
were selected with ages ranging from 4 to 8 months
and weighing 100–160kg. In the ﬁrst (kinetic)
experiment, 4 calves were sub-cutaneously injected
with 40mg ovalbumin (Sigma-Aldrich, Poole,
UK) per animal in incomplete Freund’s adjuvant
(primary response), then boosted 49 days later with
10mgovalbuminperanimalinincompleteFreund’s
adjuvant (secondary response). In the second
experiment, 8 calves in total were sub-cutaneously
injected with various doses of ovalbumin (40, 10,
1 or 0.1mg per animal) in incomplete Freund’s
adjuvant, then boosted 51 days later with 10mg
ovalbumin per animal in incomplete Freund’s
adjuvant.Bloodsamplesweretakenatvarioustime-
points following these injections. All experiments
were approved by the Institute’s ethical review
process and were in accordance with national
guidelines on animal use.
2.2. Culture media
Iscove’s Modiﬁed Dulbecco’s Medium (IMDM)
with L-Glutamine and 25mM Hepes (Gibco,
Paisley, UK) containing penicillin (100units/mL),
streptomycin (100g/mL), 1×non-essential amino
acids, 1mM sodium pyruvate and 15% heat-
inactivated horse serum (Sigma-Aldrich), subse-
quently termed complete medium.
2.3. Isolation and stimulation of bovine
peripheral blood mononuclear
cells (PBMC)
Ten milliliters of blood per calf was collected in
heparinised tubes and bovine PBMC were obtained
by density gradient centrifugation (1200 × g for
30min over Histopaque® 1.083g/mL, Sigma-
Aldrich). Fresh PBMC were stored on ice until
being used for the detection of spontaneous ASC
and/or were stimulated as described below. Brieﬂy,
20 × 106 P B M Cw e r ec u l t u r e df o r6d a y si n2 0m L
complete medium containing 5g/mL pokeweed
mitogen (PWM, Sigma-Aldrich), 2g/mL anti-
bovine CD40 mAb (ILA158, kindly donated by
ILRI, Kenya), 20ng/mL recombinant Human IL-2
(ImmunoKontact, AMS Biotechnology, Abingdon,
UK), 7.3units/mL recombinant bovine IL-10
(kindly donated by G. Entrican, Moredun Research
Institute, Penicuik, UK) or a combination of these.
At the end of the culture period, cells were
washed twice, resuspended in complete media and
stored on ice until being used for the detection
of induced ASC. Spontaneous and induced ASC
were subsequently referred to as plasma cells and
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Figure 1. Protocol and schematic representation of the B cell ELISPOT assay. (A) The B cell ELISPOT
assay was performed with freshly isolated and 6 day-stimulated PBMC for the detection of plasma
cells and memory B cells, respectively. (B) Schematic procedure of the detection of ASC by ELISPOT.
(C) Ovalbumin-speciﬁc ASC enumeration: in this example, freshly isolated PBMC from a naïve calf
immunised 7 days previously with ovalbumin were incubated overnight in pre-coated ELISPOT plates; the
cells were seeded in duplicates (upper and lower wells) starting at 5 × 105 cells per well and performing 1:2
serial dilutions down to 1.5 × 104 cells per well; at the end of the assay, ASC were enumerated by counting
the red-coloured immunospots (number indicated in bold in the lower left corner for each well) and results
were expressed as ASC number per 106 PBMC (here, 144 ± 2A S Cp e r1 0 6 PBMC were detected).
memory B cells, respectively. A representation of
this protocol is detailed in Figure 1A.
2.4. Detection of anti-ovalbumin-speciﬁc
IgG-secreting cells (plasma cells
and memory B cells)
A schematic representation of the detec-
tion procedure is shown in Figure 1B. Brieﬂy,
MultiScreen™-HA ELISPOT plates (Millipore,
Watford, UK) were coated for 2h at 37 ◦C with
20g/mL ovalbumin in carbonate buffer, pH 9.6.
Plates were washed 5 times with PBS and subse-
quently incubated for 2h at 37 ◦C with 100Lp e r
well of blocking buffer (PBS containing 4% dried
skimmed milk). Plates were then washed 5 times
with PBS and stored at 4 ◦C until use.
Fresh or 6 day-stimulated PBMC were
resuspended at 5 × 106 cells/mL and 1:2 serial
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dilutions of cells were performed in complete
medium down to 1.5 × 105 cells/mL. 100L/well
of each cell suspension (in duplicate) was added
to coated ELISPOT plates and cultured overnight
at 37 ◦Ci na5 %C O 2 incubator. Cells were then
washed off the plates using PBS containing 0.05%
Tween20 and 100L per well sheep anti-bovine
IgG conjugated to horse radish peroxidase (1/1000,
Serotec, Oxford, UK) was added to the plates
for 3h at room temperature. Plates were washed
5 times with PBS containing 0.05% Tween20 and
100L per well 3-amino-9-ethylcarbazole (AEC)
substrate (Merck Chemicals, Nottingham, UK)
was added for 1h at room temperature. Plates
were rinsed with tap water and allowed to dry
overnight at room temperature before counting
the red-coloured immunospots using the AID
ELISPOT reader (Fig. 1C). Results were expressed
as ASC number per 106 PBMC for plasma cells
and induced-ASC number per 106 cultured PBMC
for memory B cells (mean of duplicates ± SD).
2.5. Detection of total IgG-secreting cells
(plasma cells and memory B cells)
The procedure was similar to that used for the
detection of anti-ovalbumin-speciﬁc IgG secreting
cells with minor modiﬁcations as described
thereafter. For coating, ovalbumin was substituted
with 4.5g/mL mouse anti-bovine IgG mAb
(clone BG-18, Sigma-Aldrich). Fresh and 6 day-
stimulated PBMC were resuspended at 5 × 106 and
5 × 105 cells/mL, respectively, before performing
1:2 serial dilutions in complete medium and
addition of 100L/well of each cell suspension
(in duplicate) in coated ELISPOT plates. Results
were expressed as ASC number per 106 PBMC
for plasma cells and induced-ASC number per
106 cultured PBMC for memory B cells (mean of
duplicates ± SD).
2.6. Flow cytometry
PBMC stimulated for 6 days were analyzed by
indirect immunoﬂuorescence using the following
reagents: mouse anti-bovine CD4 (clone cc8),
CD8 (clone cc63) or  T cells (clone cc15)
IgG2a mAbs [13] (all were culture supernatants
diluted at 1/10 from IAH, Compton, UK) followed
by incubation with FITC-conjugated goat anti-
mouse IgG2a Ab (1/200, Southern Biotechnology
Associates, Birmingham, AL, USA). TRT6 was
used as an IgG2a isotype control mAb [4]. 5 000
viable cells per sample were analyzed using a
FACScan ﬂow cytometer (BD Biosciences, San
Jose, CA, USA).
2.7. Cell staining by May Grunwald Giemsa
and immunohistochemistry of cytospins
Cytospins (105 cells/slide) were prepared from
6 day-stimulated PBMC using a cytocentrifuge
(Cytospin II, Shandon Scientiﬁc, Cheshire, UK)
according to the manufacturer’s instructions. Some
cytospins were ﬁxed in ethanol for 5min followed
by May-Grünwald-Giemsa staining. Alternatively,
acetone-ﬁxed cytospins were stained by immuno-
histochemistry using mouse anti-bovine light chain
mAb (ILA58, culture supernatant diluted at 1/10
from IAH, Compton, UK) [21] and DakoCy-
tomation EnVision+® System (DakoCytomation,
Carpinteria, CA, USA) followed by May-
Grünwald-Giemsa staining. The numbers of
plasma cells expressing intracellular Ig and total
cells were counted in ﬁve random ×40 micro-
scopic ﬁelds (number of total cells per ﬁeld ranging
between 114 and 204) and results were expressed
as the percentage of plasma cells ± SD.
2.8. Detection of anti-ovalbumin Abs in serum
by ELISA
Anti-ovalbumin IgG concentrations in sera were
determined using a speciﬁc ELISA, as described
below. 96 well plates were coated for 1h at
room temperature with 100L per well ovalbumin
(20g/mL in carbonate buffer, pH 9.6). Plates
were washed 5 times with PBS containing 1%
Tween 20 (Sigma-Aldrich) and 100L per well of
PBS containing 1% Tween 20 and 4% skimmed
milk (blocking buffer) was added for 1h at room
temperature in order to block any non-speciﬁc
binding. After 5 washes, 100L per well blocking
buffer or 1:3 serial dilutions of sera were added
and incubated for 1h at room temperature. Plates
were subsequently washed and 100Lo fs h e e p
anti-bovine IgG coupled to horse radish peroxidase
(Serotec) diluted at 1/100 000 was added for
1h at room temperature. After washing, 100L
3,3’,5,5-tetra-methyl benzidine (TMB) substrate
(ICN biomedicals, Irvine, CA, USA) was added
and the reaction was stopped after 10 min by the
addition of 50L of 1.2M H2SO4. The optical
density (OD) values at both 450 and 690nm were
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read for each well on a SpectraMAX 250 plate
reader (Molecular devices, Sunnyvale, CA, USA) at
dual wavelength. Anti-ovalbumin IgG titres (mean
of duplicates ± SD) were calculated as follows: the
log10 OD against log10 sample dilution was plotted
and a regression analysis of the linear part of this
curve allowed calculation of the endpoint titre with
an OD of twice the background.
2.9. Statistical analysis
The Pearson’s correlation coefﬁcient (r)w a s
derived from experimental data in Excel spread-
sheets to examine the association between the
anti-ovalbumin IgG titres and the plasma cell or
memory B cell numbers detected at the selected
time points.
3. RESULTS
3.1. Polyclonal stimulation of memory B cells in
PBMC is necessary for their subsequent
detection by the ELISPOT assay
The B cell ELISPOT assay can only be
used to detect and quantify cells actively
secreting Abs. As plasma cells spontaneously
secrete Ab, these cells can be directly
detected following their culture overnight in
pre-coated ELISPOT plates. In contrast to
plasma cells, memory B cells are quiescent
cells and it is therefore necessary to induce
their differentiation into ASC prior to the
ELISPOT assay. To determine the most potent
differentiation stimuli, we incubated bovine
PBMC with various combinations of stimuli
for 6 days. The B cell ELISPOT assay
was then used to determine the number of
total IgG-secreting cells generated from 106
cultured PBMC in each culture condition.
As expected, PBMC cultured for 6 days
in media alone did not generate any ASC.
Amongst the combinations of stimuli tested,
PWM + CD40 mAb + IL-2 + IL-10 was
the most potent stimulus to induce the
differentiation of bovine PBMC, generating
8556 ± 1725 total IgG-secreting cells per
106 cultured PBMC (Fig. 2A). Using this
stimulus, we activated bovine PBMC for
various periods of time before performing
the ELISPOT assay and showed the optimal
duration of PBMC activation required for
inducing their differentiation into ASC was
6 days (Fig. 2B). This was consistent with
the ﬁndings of Crotty et al. [5]. As shown
in Figure 2C, the stimulation of PBMC with
PWM + CD40 mAb + IL-2 + IL-10 for
6 days resulted in a large proportion of blasts,
which were not present when PBMC were
cultured in media alone. Using FACS analysis,
we showed these blasts were mostly T cells
(38 ± 6% CD4+,1 6 ± 8% CD8+ and 21 ±
11% + cells, n = 3, Fig. 2D). Parallel
analysis of cytospin preparations showed
23 ± 3% of these stimulated cells were plasma
cells, expressing intracellular Ig, as shown
by their positive staining with an anti-bovine
light chain mAb (Fig. 2E). This polyclonal
stimulation, i.e. activation of PBMC for 6 days
with PWM + CD40 mAb + IL-2 + IL-10, was
subsequently used in all experiments aiming at
the detection of Ag-speciﬁc memory B cells in
the blood of immunised calves.
3.2. Ab titre, plasma cell and memory B cell
kinetics during the primary and secondary
immune responses
Using the B cell ELISPOT assay, we
sought to determine the kinetics of ovalbumin-
speciﬁc plasma cells and memory cells
appearance in the blood during the primary
and secondary immune responses and relate
these to the kinetics of Ab titres. For this
purpose, four calves were immunised with
40mg ovalbumin, boost-immunised at day
49 with 10mg ovalbumin and blood samples
were collected at various time points for the
quantiﬁcation of ovalbumin-speciﬁc Ab titres,
plasma cells and memory B cells.
The quantiﬁcation of Ab titres constitutes
the traditional method for assessing a B cell
response generated after an immunisation,
vaccination or infection and the kinetics
of Ab production has been described in
numerous reports. In agreement with these
reports, we showed that, during the primary
response, ovalbumin-speciﬁc IgG titres started
to increase between days 6 and 15 post-
immunisation and then reached a plateau
(values ranging from 26021 to 91187 on
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Figure 2. Phenotype of PBMC stimulated for 6 days with PWM, CD40 mAb, IL-2 and IL-10. (A)2 0× 106
bovine PBMC were cultured for 6 days in 20mL complete medium alone (media) or in the presence
of various combinations of PWM, CD40 mAb, IL-2 and IL-10. The number of total IgG-secreting cells
generated from 106 cultured PBMC (mean of duplicate determinations ± SD) was determined for each
culture condition. Representative data from 2 independent experiments are shown. (B)2 0× 106 PBMC
were cultured for various periods of time with PWM, CD40 mAb, IL-2 and IL-10. The number of total IgG-
secretingcells generated from106 cultured PBMC(mean ofduplicate determinations ±SD) was determined
for each time point. Representative data from 2 independent experiments are shown. (C) Cytospin slides
from fresh (day 0) and cultured (day 6) PBMC were stained with May-Grunwald-Giemsa (arrows indicate
cells with plasma cell morphology. (D-E) PBMC were stimulated for 6 days with PWM, CD40 mAb,
IL-2 and IL-10. At the end of the culture period, the phenotype of the cells in the resulting population was
analysed: ﬂow cytometry was used to determine the percentage of CD4+,C D 8 + and + T cells (D)a n d
immunohistochemistry to detect intracellular Ig (in cytospin slides) using an anti-bovine light chain mAb
and counter-staining with May-Grunwald-Giemsa (E). Representative data from 3 independent experiments
are shown. Original magniﬁcation: ×40. ASC: Ab-secreting cells.
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day 49 post-immunisation, n = 4). During the
secondary response, the Ab titres increased
from an earlier time point (between days 3 to
4) and reached much higher values (ranging
from 626241 to 1748100 on day 9 post-boost
immunisation, n = 4, Fig. 3A).
The kinetics of plasma cells detected in
the blood was very different from the kinetics
of Ab titres (Fig. 3B). Indeed, a sharp peak
of plasma cells was detected at days 6 and
7 (range: 27 to 220 ovalbumin-speciﬁc ASC
per 106 PBMC, n = 4) during the primary
response instead of the gradual increase
previously observed for Ab titres. Similarly,
we also detected a sharp peak of plasma cells
during the secondary response but, consistent
with the recognised feature of a secondary
response, this peak occured earlier (at days
3 and 4) and to a higher magnitude (range:
546 to 1781 ovalbumin-speciﬁc ASC per 106
PBMC, n = 4).
The kinetics of memory B cells detected in
the blood (following the in vitro stimulation of
PBMC for 6 days prior to performing the B
cell ELISPOT assay) are shown in Figure 3C.
During the primary response, the number of
memory B cells started to gradually increase
between days 15 and 20 and reached values
ranging from 407 to 554 ovalbumin-speciﬁc
ASC per 106 PBMC, n = 4, at day 49 post-
immunisation (corresponding to day 0 of the
boost immunisation with 10mg ovalbumin).
Following the boost immunisation, we initially
observed a reduction in the memory B cell
number detected in the blood (ranging from 16
to 58 ovalbumin-speciﬁc ASC per 106 PBMC
at days 1 and 2 post-boost immunisation,
n = 4). This reduction probably reﬂected the
recruitment of memory B cells from the blood
to the lymphoid organs. Subsequently, the
number of memory B cells peaked at days 5
and 6 post-boost immunisation. Interestingly,
the increase in memory B cells detected during
the secondary response started earlier and
was stronger (ranging from 2096 to 17920
ovalbumin-speciﬁc ASC per 106 PBMC at
days 5 and 6 post-boost immunisation, n = 4)
than during the primary response.
3.3. The Ab titres correlate with the plasma cell
numbers detected at the peak of the
secondary immune response
In order to try and establish a correlation
between the Ab titres and the peak number
of plasma cells or memory B cells generated,
we designed a new immunisation protocol
where calves were inoculated with various
doses of ovalbumin. This time, we used
8 calves in total: 2 were immunised with
40mg, 2 with 10mg, 2 with 1mg and 2
with 0.1mg ovalbumin per animal and, at day
51 post-immunisation, each of these calves
was boosted with 10mg ovalbumin. Blood
samples were then collected at the optimal
time-points determined during the previous
kinetic experiment and ovalbumin-speciﬁc Ab
titres, plasma cells and memory cells were
quantiﬁed.
During the primary response, despite
reasonable ovalbumin-speciﬁc IgG titres, the
memory B cells (assessed at days 21 and
51 post-immunisation) and plasma cells
(assessed at days 6 and 7 post-immunisation)
were detectable but their number too low
to establish a correlation between B cell
frequency and Ab response (Tab. I). Following
the boost immunisation, the number of
memory and plasma cells detected in the blood
reached much higher values at the optimal
time-points previously determined for each of
these parameters: days 3 and 4 post-boost
immunisation for plasma cells and days 5 and
6 post-boost immunisation for memory B cells
(Tab. I). Our results showed there was no clear
correlation between the doses of ovalbumin
used in the primary immunisation regime and
the Ab titres or memory B cell or plasma cell
numbers detected at the peak response during
the secondary immune response. Similarly,
no correlation was found between the anti-
ovalbumin IgG titres assessed 17 days post-
boost immunisation and the memory B
cell numbers detected at the peak response
(6 days post-boost immunisation) during
the secondary immune response (r value =
−0.05, n = 8, Fig. 4A). However, we found
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Figure 3. Kinetics of Ab titres, plasma cell and memory B cell numbers after immunisation and boost-
immunisation of calves with ovalbumin. Four calves were sub-cutaneously injected with 40mg ovalbumin
per animal in incomplete Freund’s adjuvant (primary response, left panels), then boosted 49 days later with
10mg ovalbumin per animal in incomplete Freund’s adjuvant (secondary response, right panels). Blood
samples were taken at various time-points following these injections and ovalbumin-speciﬁc IgG titres (Ab
titre, A), plasma cell (B) and memory B cell (C) numbers were determined by ELISA and B cell ELISPOT.
Results were expressed as ASC per 106 PBMC for plasma cells and induced-ASC per 106 cultured PBMC
for memory B cells (mean of duplicate determinations).
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Table I. Ab titres, plasma cell and memory B cell numbers following various immunisation regimes with
ovalbumin.
Immunisation Primary response
Calf regime Ab titre (log10) Peak plasma cell Memory B cell number before
number Primary/Secondarya (day 21 pib) number (day 7 pib) boost (day 51 pib)
#1 4 0m g / 1 0m g 4 . 4 6± 0.04 138 ± 15 44 ± 7
#2 4 0m g / 1 0m g 4 . 6 2± 0.2 146 ± 30 221 ± 32
#3 1 0m g / 1 0m g 4 . 6 5± 0.01 40 ± 72 6 ± 6
#4 1 0m g / 1 0m g 4 . 6 2± 0.11 69 ± 22 6 ± 0
# 5 1 mg/10 mg 4.1 ± 0.11 15 ± 01 7 ± 4
# 6 1 mg/10 mg 3.91 ± 0.08 53 ± 10 72 ± 32
# 7 0.1 mg/10 mg 4.49 ± 0.01 16 ± 6 124 ± 1
# 8 0.1 mg/10 mg 4.4 ± 0.07 13 ± 16 ± 0
Secondary response
Immunisation Peak plasma Peak memory B
Calf regime Ab titre (log10) Ab titre (log10) cell number cell number
number Primary/Secondarya (day 17 pbc) (5 months pbc) (day 4 pbc) ( d a y6p b c)
#1 4 0m g / 1 0m g 5 . 2 8± 0.04 4.11 ± 0.01 70 ± 19 2 021 ± 0
#2 4 0m g / 1 0m g 5 . 8 6± 0.02 4.76 ± 0.03 581 ± 44 2 222 ± 226
#3 1 0m g / 1 0m g 5 . 9 6± 0.01 4.86 ± 0.03 728 ± 79 382 ± 25
#4 1 0m g / 1 0m g 5 . 1 9± 0.01 4.1 ± 0 187 ± 7 142 ± 14
# 5 1 mg/10 mg 5.44 ± 0.05 4.09 ± 0.01 229 ± 3 352 ± 28
# 6 1 mg/10 mg 5.87 ± 0.04 4.36 ± 0.01 618 ± 33 1 553 ± 21
# 7 0.1 mg/10 mg 6.13 ± 0.02 4.81 ± 0.01 1 601 ± 226 485 ± 23
# 8 0.1 mg/10 mg 6.25 ± 0.04 5.02 ± 0 2 879 ± 433 166 ± 11
aEight calves were sub-cutaneously injected with 40, 10, 1 or 0.1mg ovalbumin per animal in incomplete Freund’s
adjuvant, and then boosted 51 days later with 10mg ovalbumin per animal in incomplete Freund’s adjuvant. Blood
samples were taken at various time-points corresponding to the peak response for ovalbumin-speciﬁc plasma
cells (day 7 pi and day 4 pb) and memory B cells (day 51 pi and day 6 pb) as well as at day 21 pi, day 17 pb
and 5 months pb for ovalbumin-speciﬁc IgG titres (Ab titre). Plasma cell and memory B cell numbers were
expressedasASCnumberper106 PBMCandinduced-ASCnumberper106 culturedPBMC,respectively(meanof
duplicates ± SD).
bpi: post-immunisation;
cpb: post-boost-immunisation.
a very strong correlation between the anti-
ovalbumin IgG titres and plasma cell numbers
detected in the blood at the peak response
(4 days post-boost immunisation) during the
secondary response (r value = 0.95, n = 8,
Fig. 4B). Interestingly, although the anti-
ovalbumin IgG titres determined at a later time
point, ﬁve months post-boost immunisation,
did not correlate with the memory B cell
numbers detected in the blood at day 6 post-
boost immunisation (r value =− 0.12, n = 8,
Fig. 4C), the ﬁve months post-boost Ab titres
did strongly correlate with the plasma cell
numbers detected in the blood at day 4 post-
boost immunisation (r value = 0.88, n = 8,
Fig. 4D).
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Figure 4. Ovalbumin-speciﬁc plasma cell numbers detected at the peak of the secondary response strongly
correlates with ovalbumin-speciﬁc IgG titres detected up to 5 months post-boost immunisation. Pearson’s
correlation coefﬁcient (r) was determined to examine the association between the Log10 anti-ovalbumin IgG
titres and the Log10 memory B cell (A)o rp l a s m ac e l l( B) numbers detected at the peak response following
the boost-injection of ovalbumin (day 17 pb, day 6 pb and day 4 pb, respectively). A similar analysis was
performed to examine the association between the Log10 anti-ovalbumin IgG titres detected 5 months later
and the Log10 memory B cell (C)o rp l a s m ac e l l( D) numbers detected at the peak response (day 6 pb and
day 4 pb, respectively); pb: post-boost.
4. DISCUSSION
Here, we describe a B cell ELISPOT assay
allowing the detection and quantiﬁcation of
circulating bovine plasma cells and memory
B cells generated, subsequent to an immunisa-
tionandaboostimmunisationwithovalbumin.
This assay enables us to detect and quantify
bovine plasma cells circulating in the blood
without any prior stimulation. Indeed, these
cells secrete large amounts of Ab when cul-
tured overnight in vitro, which constitutes the
ﬁrst step of the B cell ELISPOT assay. In con-
trast, it is necessary to induce the differentia-
tion of the quiescent memory B cells into ASC
prior to the ELISPOT assay. Human memory
B cells can be terminally differentiated using
a combination of SAC, PWM and/or CpG
ODN in the presence of recombinant human
cytokines such as IL-2, IL-10 and/or IL-15 [2,
5, 7, 20]. Here, we showed the combination
of PWM, anti-bovine CD40 mAb, recom-
binant human IL-2 and recombinant bovine
IL-10 is a potent stimulus for the terminal
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differentiation of bovine memory B cells into
Ab-secreting cells. Indeed, it is likely the
cells detected after the polyclonal stimula-
tion for 6 days were derived from memory B
cells for the following reasons. Firstly, these
cells cannot be derived from naïve B cells as
we showed no ovalbumin-speciﬁc ASC were
detected following the 6-day stimulation of
PBMC isolated on day 0 during the primary
response in naïve calves. If naïve B cells
speciﬁc for ovalbumin can be differentiated
into ASC following the polyclonal stimula-
tion for 6 days, it is possible that their ini-
tial scarcity results in a very low, undetectable
number of ASC in our ELISPOT assay. Alter-
natively, naïve B cells may not be activated
and/or terminally differentiated in our cultures
as these conditions do not provide any trigger-
ing of the B cell receptor. This hypothesis is
in agreement with a previous report published
by Bernasconi et al. who showed the stimula-
tion with anti-Ig Ab was absolutely required
to induce the proliferation and terminal dif-
ferentiation of puriﬁed naïve B cells in the
presence of bystander T cell help [2]. Sec-
ondly, the ASC detected after the 6-day poly-
clonal stimulation cannot represent plasma
cells that were present in the initial blood
sample. Indeed, it is known plasma cells die
quickly if appropriate signals, such as IL-5,
IL-6, stromal-cell-derived factor-1, tumor
necrosis factor (TNF) and ligands for CD44
are not provided [3]. Accordingly, during the
secondary response, we detected only low
numbers of ovalbumin-speciﬁc memory B
cells in the blood at day 3 post-boost immu-
nisation whereas large numbers of ovalbumin-
speciﬁc plasma cells were already detected at
this time-point (764 ± 708 and 1376 ± 319
ASC per 106 PBMC for memory B cells and
plasma cells, respectively, n = 4). It is how-
ever important to mention that the number of
inducedASCper106 culturedPBMC(referred
to as “memory B cells” in the present manu-
script) detected by the B cell ELISPOT assay
isnotequalto,butratherindirectlyreﬂects,the
number of memory B cells initially present in
theblood.Indeed,previousreportshaveshown
that B cells can divide up to 8 times following
their culture for several days in the presence of
various polyclonal stimuli, therefore amplify-
ing the ﬁnal number of ASC detected [2,6,17].
Upon the encounter of a naïve B cell with
its speciﬁc Ag and T cells, a primary humoral
response is initiated within secondary lym-
phoid organs. Some naïve B cells proliferate
and differentiate into plasma cells secreting
low afﬁnity Abs in extrafollicular areas, such
as the medullary cords in lymph nodes (LN) or
the red pulp in the spleen. These foci of ASC
develop during the ﬁrst week of the response
and subsequently involute during the second
week [16]. In parallel, a proportion of the Ag-
activated B cells migrate to the B cell areas of
secondary lymphoid organs, i.e. primary fol-
licles, where the process of afﬁnity matura-
tion takes place [10]. This process involves the
generation of secondary follicles from primary
follicles, which can be observed from day 4
to day 21 post-immunisation in the absence of
antigenic restimulation, and ultimately leads
to (i) the improved afﬁnity of serum antibod-
ies during the course of a humoral response
and (ii) the generation of plasma cells and
memory B cells speciﬁc for the immunizing
T-dependent Ag [1,8,9,18,19]. Some plasma
cells will exit the lymphoid organ and migrate
via the blood towards speciﬁc niches, such as
the bone marrow, where they can reside as
long-lived plasma cells and secrete Abs for
long periods of time. On the other hand, mem-
ory B cells do not spontaneously secrete Abs
but constantly recirculate between the blood
and tissues in a quiescent state.
Using the B cell ELISPOT assay, we
detected in the blood a burst of ovalbumin-
speciﬁc plasma cells at days 6 and 7 post-
immunisation during the primary response,
which was followed by the production of
speciﬁc Ab. The generation of memory B
cells was only detected at a later time-
point (starting between days 15 and 21) and
gradually increased. Interestingly, the timing
of the appearance of the memory B cells in the
blood is consistent with the recognised timing
required for a secondary follicle to form and
be fully mature within the draining lymphoid
organs [9].
In accordance with numerous reports, we
showed the boost immunisation induced a
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quicker and stronger secondary response.
Indeed, a burst of plasma cells was detected in
the blood at days 3 and 4, which was followed
by a strong increase in Ab titres. Moreover,
a burst of memory B cells, and not a gradual
increase, was detected at days 5 and 6 post-
boost immunisation.
Therefore, using the B cell ELISPOT assay,
we were able to determine the kinetics of
the appearance in the blood of bovine plasma
cells and memory B cells generated after
an immunisation with ovalbumin. We then
showed a strong correlation between the anti-
ovalbumin-speciﬁc IgG titres and plasma cell
numbers detected in the blood at the peak
response after secondary immunisation. Inter-
estingly, a weak correlation (Pearson correla-
tion coefﬁcient, r = 0.58) has previously been
observed in humans between the increase in
Ab level and the peak plasma cell response
following an immunisation with a polysaccha-
ride conjugate vaccine [7]. It is not clear why a
much stronger correlation between those para-
meters was obtained in our model but it is pos-
sible that this reﬂects the immunisation regime
chosen (using a strong T-dependent Ag, such
as ovalbumin). Nevertheless, our results sug-
gest it is possible to predict the intensity of
the Ab response that will be generated follow-
ing an immunisation by measuring the num-
ber of plasma cells detected in the blood at
early time points (day 3 and 4 following a
boost immunisation). Moreover, Rohner et al.
also showed a correlation between the level
of memory B cells detected in the blood fol-
lowing the primary immunisation of children
with a protein-polysaccharide conjugate vac-
cine and the maintenance of protective Ab
levels for several months afterwards [14].
Similarly, another report showed a strong
correlation in patients between serum Ab lev-
els and frequency of memory B cells under
steady state conditions several years after anti-
genic stimulation [2]. Therefore, based on our
own results and those of others, it appears the
detection and quantiﬁcation of plasma cells
and/or memory B cells following an immu-
nisation/vaccination strategy could constitute
a very effective means to predict, at an early
time point, the magnitude and maintenance of
the Ab response that will be generated after-
wards.
Acknowledgements. The authors would like to thank
the International Livestock Research Institute (ILRI,
Kenya) for providing the ILA158 mAb and Dr Gary
Entrican (Moredun Research Institute, UK) for the
recombinant bovine IL-10. We also thank Brenda
Jones and Gillian Hill for producing the hybridoma
supernatants. Financial support for this research
was given by the Biotechnology and Biological
Sciences Research Council (BBSRC, grant number
BBS/B/00549) and the Institute for Animal Health.
REFERENCES
[1] Berek C., Ziegner M., The maturation of the im-
mune response, Immunol. Today (1993) 14:400–404.
[2] Bernasconi N.L., Traggiai E., Lanzavecchia A.,
Maintenance of serological memory by polyclonal
activation of human memory B cells, Science (2002)
298:2199–2202.
[3] Cassese G., Arce S., Hauser A.E., Lehnert K.,
Moewes B., Mostarac M., Muehlinghaus G., Szyska
M., Radbruch A., Manz R.A. Plasma cell survival
is mediated by synergistic effects of cytokines
and adhesion-dependent signals, J. Immunol. (2003)
171:1684–1690.
[4] Cook J.K.A., Jones B.V., Ellis M.M., Jing L.,
Cavanagh D., Antigenic differentiation of strains
of turkey rhinotracheitis virus using monoclonal
antibodies, Avian Pathol. (1993) 22:257–273.
[5] Crotty S., Aubert R.D., Glidewell J., Ahmed
R., Tracking human antigen-speciﬁc memory B
cells: a sensitive and generalized ELISPOT system,
J. Immunol. Methods (2004) 286:111–122.
[6] HasboldJ.,CorcoranL.M.,TarlintonD.M.,Tangye
S.G., Hodgkin P.D., Evidence from the generation
of immunoglobulin G-secreting cells that stochastic
mechanisms regulate lymphocyte differentiation, Nat.
Immunol. (2004) 5:55–63.
[7] Kelly D.F., Snape M.D., Clutterbuck E.A., Green
S., Snowden C., Diggle L., et al., CRM197-conjugated
serogroup C meningococcal capsular polysaccharide,
but not the native polysaccharide, induces persistent
antigen-speciﬁc memory B cells, Blood (2006)
108:2642–2647.
[8] Kelsoe G., Life and death in germinal centers
(redux), Immunity (1996) 4:107–111.
[9] Liu Y.J., Zhang J., Lane P.J., Chan E.Y.,
MacLennan I.C., Sites of speciﬁc B cell activation in
primary and secondary responses to T cell-dependent
Page 12 of 13 (page number not for citation purpose)Assessment of B cell responses in cattle Vet. Res. (2009) 40:03
and T cell-independent antigens, Eur. J. Immunol.
(1991) 21:2951–2962.
[10] MacLennan I.C., Gulbranson-Judge A., Toellner
K.M.,Casamayor-PallejaM.,ChanE.,SzeD.M.,etal.,
The changing preference of T and B cells for partners
as T-dependent antibody responses develop, Immunol.
Rev. (1997) 156:53–66.
[11] Manz R.A., Thiel A., Radbruch A., Lifetime
of plasma cells in the bone marrow, Nature (1997)
388:133–134.
[12] Manz R.A., Hauser A.E., Hiepe F., Radbruch A.,
Maintenance of serum antibody levels, Annu. Rev.
Immunol. (2005) 23:367–386.
[13] Oldham G., Bridger J.C., Howard C.J., Parsons
K.R., In vivo role of lymphocyte subpopulations in
the control of virus excretion and mucosal antibody
responses of cattle infected with rotavirus, J. Virol.
(1993) 67:5012–5019.
[14] Rohner G.B., Snape M.D., Kelly D.F., John T.,
Morant A., Yu L.M., et al., The magnitude of the
antibody and memory B cell responses during priming
with a protein-Polysaccharide conjugate vaccine in
human infants is associated with the persistence
of antibody and the intensity of booster response,
J. Immunol. (2008) 180:2165–2173.
[15] Slifka M.K., Antia R., Whitmire J.K., Ahmed
R., Humoral immunity due to long-lived plasma cells,
Immunity (1998) 8:363–372.
[16] Smith K.G., Light A., Nossal G.J., Tarlinton
D.M., The extent of afﬁnity maturation differs between
the memory and antibody-forming cell compartments
in the primary immune response, Embo J. (1997)
16:2996–3006.
[17] Tangye S.G., Avery D.T., Deenick E.K., Hodgkin
P.D., Intrinsic differences in the proliferation of naive
and memory human B cells as a mechanism for
enhanced secondary immune responses, J. Immunol.
(2003) 170:686–694.
[18] Tarlinton D.M., Smith K.G., Dissecting afﬁnity
maturation: a model explaining selection of antibody-
forming cells and memory B cells in the germinal
centre, Immunol. Today (2000) 21:436–441.
[19] Thorbecke G.J., Amin A.R., Tsiagbe V.K.,
Biology of germinal centers in lymphoid tissue, Faseb
J. (1994) 8:832–840.
[20] Tuaillon E., Tabaa Y.A., Petitjean G., Huguet
M.F., Pajeaux G., Fondere J.M., et al., Detection
of memory B lymphocytes speciﬁc to hepatitis
B virus (HBV) surface antigen (HBsAg) from
HBsAg-vaccinated or HBV-immunized subjects by
ELISPOT assay, J. Immunol. Methods (2006) 315:
144–152.
[21] Williams D.J., Newson J., Naessens J., Quanti-
tation of bovine immunoglobulin isotypes and allo-
types using monoclonal antibodies, Vet. Immunol.
Immunopathol. (1990) 24:267–283.
(page number not for citation purpose)P a g e1 3o f1 3